10.61
price down icon0.66%   -0.07
after-market アフターアワーズ: 11.70 1.09 +10.27%
loading
前日終値:
$10.68
開ける:
$10.73
24時間の取引高:
79,677
Relative Volume:
0.56
時価総額:
$58.46M
収益:
$62.39M
当期純損益:
$-181.05M
株価収益率:
-3.6088
EPS:
-2.94
ネットキャッシュフロー:
$-142.49M
1週間 パフォーマンス:
-16.91%
1か月 パフォーマンス:
+14.46%
6か月 パフォーマンス:
-38.79%
1年 パフォーマンス:
-15.99%
1日の値動き範囲:
Value
$10.03
$10.73
1週間の範囲:
Value
$10.03
$12.91
52週間の値動き範囲:
Value
$6.50
$39.50

Atara Biotherapeutics Inc Stock (ATRA) Company Profile

Name
名前
Atara Biotherapeutics Inc
Name
セクター
Healthcare (1195)
Name
電話
805-623-4244
Name
住所
2380 CONEJO SPECTRUM ST, THOUSAND OAKS, CA
Name
職員
159
Name
Twitter
@Atarabio
Name
次回の収益日
2024-11-18
Name
最新のSEC提出書
Name
ATRA's Discussions on Twitter

ATRA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
ATRA 10.61 58.46M 62.39M -181.05M -142.49M -2.94
VRTX 450.37 115.10B 10.63B -479.80M -1.35B 13.33
REGN 744.50 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 596.74 35.07B 1.86B -40.29M -1.28B -4.16
ALNY 246.80 32.20B 2.09B -332.26M 16.06M -4.14
BNTX 108.23 25.09B 3.30B -501.07M 1.03B 11.54

Atara Biotherapeutics Inc Stock (ATRA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2022-07-20 ダウングレード Citigroup Neutral → Sell
2022-07-13 ダウングレード JP Morgan Overweight → Neutral
2022-07-13 ダウングレード Stifel Buy → Hold
2022-05-10 ダウングレード Citigroup Buy → Neutral
2021-05-13 アップグレード JP Morgan Neutral → Overweight
2020-12-09 ダウングレード Citigroup Buy → Neutral
2020-12-08 繰り返されました H.C. Wainwright Buy
2020-11-10 繰り返されました H.C. Wainwright Buy
2020-06-30 開始されました Evercore ISI Outperform
2020-06-15 開始されました H.C. Wainwright Buy
2020-04-23 アップグレード Citigroup Neutral → Buy
2019-11-08 ダウングレード JP Morgan Overweight → Neutral
2019-09-27 ダウングレード Goldman Neutral → Sell
2019-09-16 ダウングレード Jefferies Buy → Hold
2019-06-04 アップグレード Citigroup Sell → Neutral
2019-05-30 開始されました ROTH Capital Buy
2019-05-23 開始されました Stifel Buy
2019-01-23 開始されました Mizuho Buy
2018-04-10 開始されました JP Morgan Overweight
2018-03-16 開始されました Guggenheim Neutral
2018-03-05 繰り返されました Jefferies Buy
2018-02-28 ダウングレード JMP Securities Mkt Outperform → Mkt Perform
2018-02-15 ダウングレード Citigroup Neutral → Sell
2018-01-03 アップグレード Citigroup Sell → Neutral
2017-10-06 再開されました Goldman Neutral
すべてを表示

Atara Biotherapeutics Inc (ATRA) 最新ニュース

pulisher
Nov 20, 2024

Atara biotherapeutics EVP sells $11,198 in stock By Investing.com - Investing.com Australia

Nov 20, 2024
pulisher
Nov 20, 2024

Atara biotherapeutics CFO Eric Hyllengren sells $15,274 in stock - Investing.com

Nov 20, 2024
pulisher
Nov 20, 2024

Atara Biotherapeutics CEO sells shares worth $18,633 - Investing.com

Nov 20, 2024
pulisher
Nov 20, 2024

Atara Biotherapeutics CEO sells shares worth $18,633 By Investing.com - Investing.com UK

Nov 20, 2024
pulisher
Nov 20, 2024

FUJIFILM Diosynth Biotechnologies Celebrates the Expansion Completion at its California Cell Therapy Facility - GlobeNewswire Inc.

Nov 20, 2024
pulisher
Nov 18, 2024

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Given Average Recommendation of "Hold" by Brokerages - MarketBeat

Nov 18, 2024
pulisher
Nov 17, 2024

How the (ATRA) price action is used to our Advantage - Stock Traders Daily

Nov 17, 2024
pulisher
Nov 15, 2024

EcoR1 Capital, LLC Increases Stake in Atara Biotherapeutics Inc - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

Atara Biotherapeutics Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 15, 2024
pulisher
Nov 13, 2024

Atara Biotherapeutics Reports Q3 2024 Financial Progress - TipRanks

Nov 13, 2024
pulisher
Nov 13, 2024

Atara Biotherapeutics to Participate at the Stifel 2024 Healthcare Conference - Business Wire

Nov 13, 2024
pulisher
Nov 13, 2024

Atara Biotherapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 13, 2024
pulisher
Nov 13, 2024

Stifel raises Atara Bio shares target, keeps hold rating ahead of clinical data - Investing.com UK

Nov 13, 2024
pulisher
Nov 13, 2024

Atara Biotherapeutics (NASDAQ:ATRA) Price Target Raised to $21.00 - MarketBeat

Nov 13, 2024
pulisher
Nov 12, 2024

Atara Biotherapeutics: Q3 Earnings Snapshot - Houston Chronicle

Nov 12, 2024
pulisher
Nov 12, 2024

Atara Biotherapeutics (ATRA) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Nov 12, 2024
pulisher
Nov 12, 2024

Earnings Flash (ATRA) ATARA BIOTHERAPEUTICS Reports Q3 Revenue $40.2M - Marketscreener.com

Nov 12, 2024
pulisher
Nov 12, 2024

Atara Bio Q3 Revenue Soars 1,814% to $40.2M, FDA Decision Looms for Tab-cel Drug | ATRA Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 06, 2024

(ATRA) On The My Stocks Page - Stock Traders Daily

Nov 06, 2024
pulisher
Nov 06, 2024

Atara Biotherapeutics (ATRA) to Release Quarterly Earnings on Tuesday - MarketBeat

Nov 06, 2024
pulisher
Nov 06, 2024

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Surges 34% Yet Its Low P/S Is No Reason For Excitement - Simply Wall St

Nov 06, 2024
pulisher
Nov 05, 2024

Atara Biotherapeutics to Announce Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 - Business Wire

Nov 05, 2024
pulisher
Nov 05, 2024

Vanguard Group Inc's Strategic Acquisition in Atara Biotherapeutics Inc - GuruFocus.com

Nov 05, 2024
pulisher
Nov 03, 2024

Net Present Value Model: Atara Biotherapeutics Inc’s ATA-3219 - GlobalData

Nov 03, 2024
pulisher
Oct 31, 2024

Hemophagocytic Lymphohistiocytosis Market to Reach New Heights in Growth by 2034, DelveInsight Predict | Incyte, Novartis, Atara Biotherapeutics, Bellicum Pharma - The Globe and Mail

Oct 31, 2024
pulisher
Oct 27, 2024

(ATRA) Trading Signals - Stock Traders Daily

Oct 27, 2024
pulisher
Oct 16, 2024

Atara Biotherapeutics names new COO By Investing.com - Investing.com Australia

Oct 16, 2024
pulisher
Oct 15, 2024

Atara Biotherapeutics names new COO - Investing.com

Oct 15, 2024
pulisher
Oct 15, 2024

Atara Biotherapeutics, Inc. Appoints Eric Hyllengren as Chief Operating Officer - Marketscreener.com

Oct 15, 2024
pulisher
Oct 15, 2024

Atara Biotherapeutics (ATRA) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Oct 15, 2024
pulisher
Oct 05, 2024

How to Take Advantage of moves in (ATRA) - Stock Traders Daily

Oct 05, 2024
pulisher
Oct 04, 2024

Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Oct 04, 2024
pulisher
Sep 30, 2024

After scoring a first for an off-the-shelf T cell therapy, can Atara maintain momentum? - Yahoo Finance

Sep 30, 2024
pulisher
Sep 27, 2024

Pancreatic Cancer Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Dragonfly Therapeutics, Keymed B, Tango Therapeutics, Atara Biotherapeutics, Keymed Biosciences Co. Ltd - Barchart

Sep 27, 2024
pulisher
Sep 24, 2024

Trading (ATRA) With Integrated Risk Controls - Stock Traders Daily

Sep 24, 2024
pulisher
Sep 14, 2024

How To Trade (ATRA) - Stock Traders Daily

Sep 14, 2024
pulisher
Sep 11, 2024

Atara Therapeutics appoints Cokey Nguyen as chief executive - The Pharma Letter

Sep 11, 2024
pulisher
Sep 09, 2024

Atara Biotherapeutics Sees Its Stock Price Rise - Los Angeles Business Journal

Sep 09, 2024
pulisher
Sep 06, 2024

Atara Biotherapeutics (ATRA) Stock Is Up 20%: What's Going On? - MSN

Sep 06, 2024
pulisher
Sep 05, 2024

Atara Biotherapeutics Inc [ATRA] President and CEO makes an insider purchase of 3,038 shares worth 20139.0. - Knox Daily

Sep 05, 2024
pulisher
Sep 04, 2024

Atara Biotherapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan

Sep 04, 2024
pulisher
Sep 04, 2024

Atara Biotherapeutics (ATRA) Secures Strategic Investments to Advance T-cell Immunotherapy Innovations - BP Journal

Sep 04, 2024
pulisher
Sep 03, 2024

Atara Biotherapeutics secures $36 million in stock sale - Investing.com

Sep 03, 2024
pulisher
Sep 03, 2024

Atara Biotherapeutics Shares Climb on $36 Million Direct Offering - MarketWatch

Sep 03, 2024
pulisher
Sep 03, 2024

Atara Biotherapeutics Announces Board Appointment and Capital Raise - TipRanks

Sep 03, 2024
pulisher
Sep 03, 2024

Atara Biotherapeutics Announces $36 Million Registered Direct Offering - StockTitan

Sep 03, 2024
pulisher
Sep 02, 2024

Atara Biotherapeutics Inc’s latest rating changes from various analysts - Knox Daily

Sep 02, 2024
pulisher
Aug 29, 2024

(ATRA) Proactive Strategies - Stock Traders Daily

Aug 29, 2024
pulisher
Aug 21, 2024

Atara Biotherapeutics EVP sells over $7k in company stock - Investing.com India

Aug 21, 2024
pulisher
Aug 21, 2024

Atara biotherapeutics EVP sells shares worth over $6,300 - Investing.com India

Aug 21, 2024
pulisher
Aug 21, 2024

Atara Biotherapeutics EVP sells over $7k in company stock By Investing.com - Investing.com South Africa

Aug 21, 2024

Atara Biotherapeutics Inc (ATRA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Atara Biotherapeutics Inc (ATRA) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Hyllengren Eric J
EVP, CFO and COO
Nov 18 '24
Sale
11.20
1,364
15,274
23,392
Nguyen AnhCo
President and CEO
Nov 18 '24
Sale
11.20
1,664
18,633
77,454
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
大文字化:     |  ボリューム (24 時間):